Ajanta Pharma Limited (NSE:AJANTPHARM)
2,585.20
-120.90 (-4.47%)
May 2, 2025, 3:29 PM IST
Ajanta Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 1,762 | 1,295 | 3,298 | 2,064 | 1,775 | Upgrade
|
Short-Term Investments | - | - | - | - | 250 | Upgrade
|
Trading Asset Securities | 4,387 | 3,301 | 5,103 | 1,219 | 1,757 | Upgrade
|
Cash & Short-Term Investments | 6,150 | 4,595 | 8,401 | 3,282 | 3,782 | Upgrade
|
Cash Growth | 33.82% | -45.30% | 155.96% | -13.21% | 40.33% | Upgrade
|
Accounts Receivable | 11,827 | 12,468 | 10,569 | 10,198 | 7,384 | Upgrade
|
Other Receivables | - | 696.6 | 459.2 | 460.5 | 862.2 | Upgrade
|
Receivables | 11,853 | 13,505 | 11,202 | 10,722 | 8,327 | Upgrade
|
Inventory | 9,039 | 8,284 | 8,156 | 7,911 | 7,665 | Upgrade
|
Prepaid Expenses | - | 259.2 | 164.4 | 155.8 | 138.4 | Upgrade
|
Other Current Assets | 1,390 | 666.4 | 416.2 | 573.6 | 364.2 | Upgrade
|
Total Current Assets | 28,430 | 27,309 | 28,340 | 22,645 | 20,276 | Upgrade
|
Property, Plant & Equipment | 18,918 | 17,210 | 16,982 | 16,474 | 16,296 | Upgrade
|
Long-Term Investments | 252.4 | 227.4 | 290 | 294.2 | 39.5 | Upgrade
|
Other Intangible Assets | 465.2 | 146.6 | 77.5 | 90.2 | 107.9 | Upgrade
|
Long-Term Deferred Tax Assets | 1,864 | 1,345 | 967.7 | 555.5 | 501 | Upgrade
|
Other Long-Term Assets | 219.6 | 146.4 | 133.4 | 497.1 | 566.8 | Upgrade
|
Total Assets | 50,150 | 46,384 | 46,790 | 40,556 | 37,787 | Upgrade
|
Accounts Payable | 4,542 | 4,632 | 4,228 | 3,272 | 3,739 | Upgrade
|
Accrued Expenses | 233.5 | 671.3 | 356.8 | 375.9 | 352.1 | Upgrade
|
Short-Term Debt | - | 15.6 | 38.4 | 94.9 | 63.9 | Upgrade
|
Current Portion of Leases | 127 | 117.6 | 94.3 | 64.6 | 115.9 | Upgrade
|
Current Income Taxes Payable | 405.3 | 447.7 | 330.7 | 79.4 | 489.2 | Upgrade
|
Current Unearned Revenue | - | 3.3 | 3.3 | 3.3 | 3.3 | Upgrade
|
Other Current Liabilities | 4,653 | 3,070 | 6,342 | 2,584 | 1,723 | Upgrade
|
Total Current Liabilities | 9,961 | 8,958 | 11,393 | 6,474 | 6,486 | Upgrade
|
Long-Term Leases | 347.2 | 235.2 | 262 | 185.7 | 197.7 | Upgrade
|
Long-Term Unearned Revenue | 20 | 23.4 | 26.7 | 30 | 33.4 | Upgrade
|
Long-Term Deferred Tax Liabilities | 1,105 | 1,085 | 977.2 | 1,019 | 921.7 | Upgrade
|
Other Long-Term Liabilities | 813.2 | 274.1 | 228.4 | 204.1 | 180.9 | Upgrade
|
Total Liabilities | 12,247 | 10,710 | 12,910 | 7,912 | 7,831 | Upgrade
|
Common Stock | 250.7 | 251.8 | 251.8 | 170.8 | 173 | Upgrade
|
Additional Paid-In Capital | - | 1.8 | - | - | - | Upgrade
|
Retained Earnings | - | 35,254 | 33,523 | 32,495 | 29,726 | Upgrade
|
Comprehensive Income & Other | 37,652 | 166.2 | 105 | -22.1 | 57.7 | Upgrade
|
Shareholders' Equity | 37,903 | 35,674 | 33,880 | 32,643 | 29,956 | Upgrade
|
Total Liabilities & Equity | 50,150 | 46,384 | 46,790 | 40,556 | 37,787 | Upgrade
|
Total Debt | 474.2 | 368.4 | 394.7 | 345.2 | 377.5 | Upgrade
|
Net Cash (Debt) | 5,675 | 4,227 | 8,006 | 2,937 | 3,404 | Upgrade
|
Net Cash Growth | 34.26% | -47.20% | 172.60% | -13.73% | 78.36% | Upgrade
|
Net Cash Per Share | 45.34 | 33.55 | 62.49 | 22.65 | 26.06 | Upgrade
|
Filing Date Shares Outstanding | 124.87 | 126.68 | 125.91 | 128.12 | 129.8 | Upgrade
|
Total Common Shares Outstanding | 124.87 | 126.68 | 125.91 | 128.12 | 129.8 | Upgrade
|
Working Capital | 18,469 | 18,352 | 16,947 | 16,171 | 13,790 | Upgrade
|
Book Value Per Share | 303.53 | 281.60 | 269.07 | 254.78 | 230.79 | Upgrade
|
Tangible Book Value | 37,438 | 35,527 | 33,802 | 32,553 | 29,848 | Upgrade
|
Tangible Book Value Per Share | 299.81 | 280.44 | 268.45 | 254.08 | 229.96 | Upgrade
|
Land | - | 1,488 | 1,577 | 1,575 | 1,556 | Upgrade
|
Buildings | - | 6,174 | 6,057 | 5,870 | 5,677 | Upgrade
|
Machinery | - | 14,692 | 13,879 | 13,276 | 12,614 | Upgrade
|
Construction In Progress | - | 2,565 | 2,095 | 1,529 | 1,082 | Upgrade
|
Leasehold Improvements | - | - | - | 10.9 | 11.7 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.